Variant report
Variant | nsv592366 |
---|---|
Chromosome Location | chr3:162718988-162768964 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:209)
- CpG islands (count:0)
- Chromatin interactive region (count:9)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr3:162729383-162729666 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | CEBPB | chr3:162729092-162729733 | Hela-S3 | cervix: | n/a | n/a |
3 | CEBPB | chr3:162729522-162729600 | A549 | lung: | n/a | n/a |
4 | CEBPB | chr3:162729220-162729874 | MCF-7 | breast: | n/a | n/a |
5 | CEBPB | chr3:162729049-162729851 | MCF-7 | breast: | n/a | n/a |
6 | CTCF | chr3:162760960-162761110 | Hela-S3 | cervix: | n/a | n/a |
7 | CTCF | chr3:162761000-162761150 | HCPEpiC | choroid plexus: | n/a | n/a |
8 | CTCF | chr3:162761000-162761150 | HCT-116 | colon: | n/a | n/a |
9 | CTCF | chr3:162760960-162761110 | HepG2 | liver: | n/a | n/a |
10 | CTCF | chr3:162760938-162761184 | Gliobla | brain: | n/a | n/a |
11 | CTCF | chr3:162760915-162761248 | MCF-7 | breast: | n/a | n/a |
12 | CTCF | chr3:162760960-162761179 | Hela-S3 | cervix: | n/a | n/a |
13 | CTCF | chr3:162760980-162761130 | Hela-S3 | cervix: | n/a | n/a |
14 | CTCF | chr3:162761020-162761170 | HMEC | breast: | n/a | n/a |
15 | CTCF | chr3:162761037-162761116 | GM10266 | blood: | n/a | n/a |
16 | CTCF | chr3:162761040-162761190 | HCM | heart: | n/a | n/a |
17 | CTCF | chr3:162760980-162761130 | HPAF | blood vessel: | n/a | n/a |
18 | CTCF | chr3:162760894-162761397 | HCT-116 | colon: | n/a | n/a |
19 | CTCF | chr3:162760981-162761164 | HepG2 | liver: | n/a | n/a |
20 | CTCF | chr3:162760960-162761110 | WERI-Rb-1 | eye: | n/a | n/a |
21 | CTCF | chr3:162761060-162761210 | HVMF | connective: | n/a | n/a |
22 | CTCF | chr3:162761020-162761170 | MCF-7 | breast: | n/a | n/a |
23 | CTCF | chr3:162761000-162761150 | HAc | cerebellar: | n/a | n/a |
24 | CTCF | chr3:162760962-162761122 | HepG2 | liver: | n/a | n/a |
25 | CTCF | chr3:162761040-162761190 | GM12868 | blood: | n/a | n/a |
26 | CTCF | chr3:162761000-162761150 | HPF | lung: | n/a | n/a |
27 | CTCF | chr3:162760920-162761070 | GM12875 | blood: | n/a | n/a |
28 | CTCF | chr3:162760983-162761127 | A549 | lung: | n/a | n/a |
29 | CTCF | chr3:162761000-162761150 | GM12878 | blood: | n/a | n/a |
30 | CTCF | chr3:162753290-162753354 | GM13976 | blood: | n/a | n/a |
31 | CTCF | chr3:162761000-162761150 | HFF | foreskin: | n/a | n/a |
32 | CTCF | chr3:162760979-162761209 | LNCaP | prostate: | n/a | n/a |
33 | CTCF | chr3:162761060-162761210 | HRE | kidney: | n/a | n/a |
34 | CTCF | chr3:162760985-162761103 | SK-N-SH_RA | brain: | n/a | n/a |
35 | CTCF | chr3:162760883-162761247 | GM12878 | blood: | n/a | n/a |
36 | CTCF | chr3:162760980-162761130 | HEEpiC | esophagus: | n/a | n/a |
37 | CTCF | chr3:162760960-162761110 | AG09309 | skin: | n/a | n/a |
38 | CTCF | chr3:162760939-162761223 | MCF-7 | breast: | n/a | n/a |
39 | CTCF | chr3:162761020-162761170 | SK-N-SH_RA | brain: | n/a | n/a |
40 | CTCF | chr3:162761020-162761170 | WI-38 | lung: | n/a | n/a |
41 | CTCF | chr3:162761000-162761150 | BE2_C | brain: | n/a | n/a |
42 | CTCF | chr3:162761060-162761210 | NB4 | blood: | n/a | n/a |
43 | CTCF | chr3:162760955-162761178 | ProgFib | skin: | n/a | n/a |
44 | CTCF | chr3:162761040-162761190 | GM12864 | blood: | n/a | n/a |
45 | CTCF | chr3:162761020-162761170 | AG04450 | lung: | n/a | n/a |
46 | CTCF | chr3:162761020-162761170 | RPTEC | kidney: | n/a | n/a |
47 | CTCF | chr3:162760982-162761149 | GM19238 | blood: | n/a | n/a |
48 | CTCF | chr3:162761040-162761190 | A549 | lung: | n/a | n/a |
49 | CTCF | chr3:162760932-162761197 | MCF-7 | breast: | n/a | n/a |
50 | CTCF | chr3:162760989-162761173 | LNCaP | prostate: | n/a | n/a |
No data |
(count:9 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:162730866..162732605-chr3:162732763..162734314,2 | MCF-7 | breast: | |
2 | chr3:162730866..162732605-chr3:162732763..162734314,2 | MCF-7 | breast: | |
3 | chr3:162494680..162495563-chr3:162760633..162761552,3 | MCF-7 | breast: | |
4 | chr3:162754967..162757825-chr3:162758379..162760616,2 | MCF-7 | breast: | |
5 | chr3:162755966..162757761-chr3:162760804..162762764,2 | MCF-7 | breast: | |
6 | chr3:162755966..162757761-chr3:162760804..162762764,2 | MCF-7 | breast: | |
7 | chr14:60627662..60628534-chr3:162740219..162740719,2 | MCF-7 | breast: | |
8 | chr3:162003324..162004086-chr3:162760294..162761113,2 | MCF-7 | breast: | |
9 | chr3:162754967..162757825-chr3:162758379..162760616,2 | MCF-7 | breast: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-OTOL1-2 | chr3:162744184-162744286 | NONHSAT093026 |
2 | lnc-OTOL1-2 | chr3:162744184-162744286 | ENSG00000241168.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000241168 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs557819778 | chr3:162724805-162724806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs373577404 | chr3:162724826-162724827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs1488176 | chr3:162724843-162724844 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs148697553 | chr3:162724868-162724869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs1488175 | chr3:162724877-162724878 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs180707174 | chr3:162724881-162724882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541767162 | chr3:162724927-162724928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs555628023 | chr3:162725011-162725012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs1488174 | chr3:162725033-162725034 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs1488173 | chr3:162725052-162725053 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs9283624 | chr3:162725098-162725099 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs142778635 | chr3:162725122-162725123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs151046587 | chr3:162725141-162725142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs9283625 | chr3:162725151-162725152 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs529499733 | chr3:162725180-162725181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs140987408 | chr3:162725200-162725201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs186013465 | chr3:162725205-162725206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs76756948 | chr3:162725222-162725223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs144723523 | chr3:162725227-162725228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs189738088 | chr3:162725228-162725229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs12637768 | chr3:162725275-162725276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs113601642 | chr3:162725300-162725301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs141766362 | chr3:162725330-162725331 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs6799495 | chr3:162725338-162725339 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs10559077 | chr3:162725418-162725419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs57644318 | chr3:162725421-162725422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs398062985 | chr3:162725426-162725427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs181372336 | chr3:162725448-162725449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs147106774 | chr3:162725461-162725462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs376873500 | chr3:162725491-162725492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs575519892 | chr3:162725522-162725523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs570648526 | chr3:162725537-162725538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs186034744 | chr3:162725583-162725584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs113319132 | chr3:162735411-162735412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs112618151 | chr3:162735423-162735424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs535994291 | chr3:162735451-162735452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs549058671 | chr3:162735510-162735511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs7642479 | chr3:162735564-162735565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs143773062 | chr3:162735582-162735583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs147456845 | chr3:162735583-162735584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574674395 | chr3:162735589-162735590 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs111367738 | chr3:162735608-162735609 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs542142908 | chr3:162735623-162735624 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs534698983 | chr3:162735626-162735627 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs190024368 | chr3:162735632-162735633 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs1586501 | chr3:162735677-162735678 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs35786055 | chr3:162735734-162735735 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs397719674 | chr3:162735741-162735742 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs150805385 | chr3:162735742-162735743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs552977652 | chr3:162735817-162735818 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Bladder cancer | 21909424 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:162724800-162725600 | Enhancers | Dnd41 | blood |
2 | chr3:162735400-162745200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
3 | chr3:162735600-162736400 | Enhancers | Fetal Heart | heart |
4 | chr3:162736600-162737400 | Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chr3:162741000-162765600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
6 | chr3:162745200-162745600 | ZNF genes & repeats | HUES6 Cell Line | embryonic stem cell |
7 | chr3:162745600-162746000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
8 | chr3:162752200-162752800 | Enhancers | Dnd41 | blood |
9 | chr3:162752800-162753200 | Weak transcription | Dnd41 | blood |
10 | chr3:162753200-162753400 | Enhancers | Dnd41 | blood |
11 | chr3:162753400-162756000 | Weak transcription | Dnd41 | blood |
12 | chr3:162756000-162756800 | Enhancers | Dnd41 | blood |
13 | chr3:162756800-162757200 | Weak transcription | Dnd41 | blood |
14 | chr3:162757200-162758000 | Enhancers | Dnd41 | blood |
15 | chr3:162762000-162763200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
16 | chr3:162762600-162763400 | Enhancers | Adipose Nuclei | Adipose |
17 | chr3:162762600-162764000 | Enhancers | Dnd41 | blood |
18 | chr3:162764000-162764400 | Flanking Active TSS | Dnd41 | blood |
19 | chr3:162764400-162765000 | Enhancers | Dnd41 | blood |
20 | chr3:162765000-162769000 | Weak transcription | Dnd41 | blood |
21 | chr3:162765600-162766000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |